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Purpose: Claudins are the main constituents of tight junctions. Little is 
known about their expression and localization in the normal bronchial 
epithelium and in lung cancer. 
Patients and methods: 104 lung cancer tissue blocks were studied 
including 46 adenocarcinomas (ADC), 30 squamous cell carcinomas 
(SCC), 15 small cell lung cancers (SCLC), 8 typical and 5 atypical 
carcinoids. All slides contained normal bronchial mucosa as well. Im-
munohistochemistry using antibodies against claudins-1,-2,-3,-4, and 
-7 proteins, as well as semi-quantitative estimation were performed. 
RT-PCR analysis was also carried out in 22 mmunohistochemically 
representative tumor samples. 
Results: Normal bronchial epithelial cells expressed all the examined 
claudin proteins. When compared, SCLCs and carcinoids showed 
striking differences in regard to claudins-1,-3, and -4 expressions 
(p<0.0001, p<0.0001, and p<0.0004, respectively), whereas ADCs and 
SCCs revealed signiﬁcant differences in claudins-3,-4, and -7 expres-
sions (p<0.0001, p<0.0001, and p<0.0053, respectively). However, 
comparison of ADCs with SCLCs revealed signiﬁcant difference only 
in claudin-2 expression (p<0.0002). The comparison of ADCs and 
carcinoids resulted in signiﬁcant differences regarding claudins-1,-3, 
and -4 expressions (p<0.0006, p<0.0001, and p<0.0001, respectively). 
SCCs and SCLCs varied in respect to claudins-2,-3, and -4 expressions 
(p<0.0009, p<0.0001, and p<0.0019, respectively), whereas SCCs and 
carcinoids showed different claudin-1 and -4 expressions (p<0.0076, 
and p<0.0045, respectively). RT-PCR analysis revealed parallel 
changes in the mRNA and protein expression of certain claudins. 
Conclusions: The observed distinct claudin expression proﬁle within 
the non-small cell lung cancer group, further, the marked differences 
between SCLCs and carcinoids may have differential diagnostic im-
pact, and the overexpression of certain claudins might have therapeutic 
implications.
P3-013 BSTB: Molecular Pathology Posters, Wed, Sept 5 – Thur, Sept 6 
K-ras codon 12 mutations in Non Small Cell Lung Cancer: high 
incidence of mutations in endobronchial tissue 
Moreno Acosta, Pablo1 Barba Rueda, Omaira1 Espinel, Clara2 Romero, 
Alfredo3 García Herreros, Plutarco1 Molano Luque, Monica1 Ramirez 
Gómez, Diana Mercedes1 
1 Instituto Nacional de Cancerología, Bogotá, Colombia 2 Universi-
dad Nacional de Colombia, Bogotá, Colombia 3 Instituto Nacional de 
Colombia, Bogotá, Colombia 
Lung cancer is a main cause of cancer death worldwide. In Colombia, 
the incidence and mortality of lung cancer are high. On 2002, it oc-
cupied the third place of incidence in men (20.2 by each 100000) and 
the ﬁfth place in women (10.1 by each 100000). In the last years an 
increase of incidence in non-small-cell lung cancers (NSCLC) has been 
observed, particularly of adenocarcinoma. A proportion of NSCLC 
contains mutated K-ras oncogene. Some risk factors as cigarette smok-
ing and gender have been associated also with the development of this 
cancer. The aim of this study was to determine the incidence of K-ras 
mutations (codon 12) in patients diagnosed with NSCLC who attended 
at the Pneumology and Thoracic Surgery Services of the National 
Cancer Institute. 
7 samples of endobronchial tissue, 11 samples of bronchoalveolar 
lavage (BAL) and 52 samples of parafﬁn-embedded tissue were ob-
tained of 66 patients before receive treatment. For the analysis of K-ras 
mutations (codon 12) it was developed an enriched PCR technique with 
modiﬁcations done according to the kind of samples. 
We identiﬁed 66 patients with non-small-cell lung cancer (adenocar-
cinomas: n=38; squamous cell carcinoma: n=26; large cell carcinoma: 
n=2; TNM stages I-IV) of them 18 were women and 48 were men (rank 
of age 35-84 years). 18 mutations were detected in 70 samples (25.7%), 
distributed in 5/7 endobronchial tissue (71.4%), 3/11 BAL (27.2%) and 
10/52 parafﬁn-embedded tissue (19.2%). Of these 18 mutations, 14 
(77.7%) belong to adenocarcinoma type (14/38, 36.8%), 3 (16.6%) to 
squamous cell carcinoma type (3/26, 11.5%) and 1 (5.5%) to large cell 
carcinoma (1/2, 50%). Of the detected mutations, 15 were found in men 
(mean age of 68 years) and all of them were smokers. The 3 additional 
mutations were detected in women (mean age of 66 years) that were 
non smokers. All samples that had the K-ras mutations belong to stages 
III or IV. 
The high incidence of K-ras mutations at codon 12 was observed in 
endobronchial tissue, due to the high amount of tumor cells found in 
the biopsy. In addition these mutations were more common in adeno-
carcinomas than in squamous cell carcinoma, suggesting a possible 
association between the presence of the mutation and the adenocarci-
noma type. These results are similar to other reports for the carrying 
population of mutations K-ras at codon 12. This research contributes to 
our understanding of the role that these mutations play as risk factors of 
Non Small Cell Lung Cancer in our population.
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Aim: Endothelin-1 (ET-1) is a potent mitogen involved in tumor cell 
growth. The aim of this study is to explore the role of calcium inﬂux 
in ET-1-induced proliferation of human lung adenocarcinoma cells 
SPC-A1. 
Methods: Cell number was measured by MTT (3-[4,5-dimethylthiazol-
2-yl]-2, 5-diphenyl-tetrazolium bromide) assay. Ca2+ concentration 
was measured by Fura-2/AM ﬂuorescent assay. 
Result: ET-1 (10-15 mol/L-10-8 mol/L) enhanced SPC-A1 cell growth 
and increase [Ca2+]i in a dose-dependent manner( p<0.05) in vitro. 
Effect of ET-1 (10-10 mol/L) on the proliferation of SPC-A1 cells and 
the increase of [Ca2+]i was blocked by BQ123 (10-7 mol/L), a highly 
selective endothelin receptor A (ETA) antagonist ( p<0.05), not by 
BQ788 (10-7 mol/L) ( p>0.05), a highly selective endothelin recep-
tor B(ETB) antagonist. Deletion of extracellular Ca2+ with Ethylene 
Diamine Tetraacetic Acid (EDTA,0.4mmol/L) or blockade of voltage 
dependent calcium channel with nifedipine (1umol/L) signiﬁcantly re-
duce ET-1-induced increase of [Ca2+]i and proliferation of cell growth. 
Conclusion: endothelin-1 enhances both the proliferation and the 
increase of [Ca2+]i by the activation of ETA receptor in SPC-A1 cells. 
Ca2+ inﬂux from voltage dependent calcium channel may play a great 
role in this precess.
